We addressed this challenge by obtaining different crystal forms of MraYAA in the presence of camelid single-chain antibodies called nanobodies
We addressed this challenge by obtaining different crystal forms of MraYAA in the presence of camelid single-chain antibodies called nanobodies. present crystal structures of MraY in complex with representative users of the liposidomycin/caprazamycin, capuramycin, and mureidomycin classes of nucleoside inhibitors. Our structures reveal cryptic druggable warm spots in the shallow inhibitor binding site of MraY…